Procurement Policy | List of Frontiers open access articles

Original Research

Published on 30 May 2023

Does China’s centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model

in Drugs Outcomes Research and Policies

Yang Gu
Qian Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192423

13,970 views
13 citations

Original Research

Published on 20 Aug 2024

Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China

in Drugs Outcomes Research and Policies

Jingying Gao
Chaojie Liu
Yinming Li
Xizhuo Chen
Tianqin Xue
Yuqing Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362374

2,477 views

Original Research

Published on 30 Jan 2025

Impact of zero-markup consumable policy and national procurement of coronary stents on hospitalization expenses: an interrupted time series analysis

in Public Health Policy

Shao-long Wu
Kun Wang
Xin Yang
Ning Liu
Wen-xin Zou
Xiao-wei Li
Dan-hua Huang
Tian-hao Yu

Frontiers in Public Health

doi 10.3389/fpubh.2025.1364116

2,642 views
2 citations

Original Research

Published on 27 Jun 2024

Does China’s national volume-based drug procurement policy promote or hinder pharmaceutical innovation?

in Drugs Outcomes Research and Policies

Xiujuan Li
Jiachun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392239

9,042 views
12 citations

Original Research

Published on 01 Feb 2022

Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design

in Health Economics

Yu-Fei Hua
Jin Lu
Bing Bai
Han-Qing Zhao

Frontiers in Public Health

doi 10.3389/fpubh.2021.809453

12,395 views
17 citations

Original Research

Published on 14 Mar 2025

Comparative study on government subsidy models for competitive drug supply chains under centralized procurement policy

in Health Economics

Yan Wen
Yan Wei
Lu Liu

Frontiers in Public Health

doi 10.3389/fpubh.2025.1542858

3,002 views
3 citations

Brief Research Report

Published on 22 Feb 2023

Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine

in Drugs Outcomes Research and Policies

Chao Zhang
Yudan Ding
Zhenzhen Wu
Juan Wang
Xiangping Wu
Weiwei Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097600

3,836 views
2 citations

Original Research

Published on 02 Jul 2025

Will centralized drug procurement policy improve enterprises’ total factor productivity?

in Public Health Policy

Xin Li
Ran Tao
Wenxue Zou
Yuning Jin

Frontiers in Public Health

doi 10.3389/fpubh.2025.1504342

2,230 views

Original Research

Published on 20 Feb 2024

Effect of China national centralized drug procurement policy on anticoagulation selection and hemorrhage events in patients with AF in Suining

in Cardiovascular and Smooth Muscle Pharmacology

Qi Zhang
Ruili Wang
Lei Chen
Wensu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365142

3,405 views
5 citations

Original Research

Published on 21 Feb 2025

Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis

in Drugs Outcomes Research and Policies

Zhi-Hang Lin
Can-Ming Wang
Li-Li Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1458792

1,727 views
1 citation

Original Research

Published on 25 Aug 2025

Effects of national volume-based procurement policy on the usage and expenditure of platinum antineoplastic drugs in China: an interrupted time series study

in Drugs Outcomes Research and Policies

Xihui Yu
Hailing Lin
Bin Li
Hongbo Fu
Yaofeng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593099

2,318 views

Original Research

Published on 29 Aug 2019

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis

in Drugs Outcomes Research and Policies

Shuchen Hu
Chen Chen
Shengfang Yuan
Fei Xue
Li Shi
Yu Fang
Caijun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00950

4,789 views
9 citations

Original Research

Published on 07 Oct 2022

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

in Drugs Outcomes Research and Policies

Anqi Huang
Xuanxuan Wang
Yun Tao
Likai Lin
Hong Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.996824

6,210 views
13 citations

Original Research

Published on 30 Oct 2025

Analysis of structural variations and effects of the national volume-based procurement policy on inpatient costs: a real world study of osteoporotic hip fractures in Shanghai, China

in Health Economics

Jing Yan
Qiujun Qin
Xinye Fang
Fen Li
Bifan Zhu

Frontiers in Public Health

doi 10.3389/fpubh.2025.1678817

968 views

Original Research

Published on 01 Jul 2024

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises’ R&D investment: a difference-in-differences analysis in China

in Public Health Policy

Jiaming Li
Xinyue Zhang
Rui Wang
Keyao Cao
Luhui Wan
Xu Ren
Jinxi Ding
Wei Li

Frontiers in Public Health

doi 10.3389/fpubh.2024.1402581

7,077 views
4 citations

Original Research

Published on 08 Feb 2024

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients

in Drugs Outcomes Research and Policies

Lili Shang
Yan Cheng
Jifang Zhou
Yuqing Bao
Desong Kong
Ruijian Huang
Yanfei Chen
Hao Wang
Ning Gu
Aixia Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302154

5,144 views
7 citations

Articles

Does China’s centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model

Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China

Impact of zero-markup consumable policy and national procurement of coronary stents on hospitalization expenses: an interrupted time series analysis

Does China’s national volume-based drug procurement policy promote or hinder pharmaceutical innovation?

Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design

Comparative study on government subsidy models for competitive drug supply chains under centralized procurement policy

Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine

Will centralized drug procurement policy improve enterprises’ total factor productivity?

Effect of China national centralized drug procurement policy on anticoagulation selection and hemorrhage events in patients with AF in Suining

Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis

Effects of national volume-based procurement policy on the usage and expenditure of platinum antineoplastic drugs in China: an interrupted time series study

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study

Analysis of structural variations and effects of the national volume-based procurement policy on inpatient costs: a real world study of osteoporotic hip fractures in Shanghai, China

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises’ R&D investment: a difference-in-differences analysis in China

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients